The Impact Of Reduced Plasmodium Falciparum And Plasmodium Vivax Transmission On The Epidemiology Of Malaria And The Acquisition Of Antigen-specific Recall Responses In Children From Papua New Guinea.
Funder
National Health and Medical Research Council
Funding Amount
$365,166.00
Summary
Malaria represents a significant global health burden in endemic countries. Individuals gradually develop a level of immunity to the clinical symptoms of malaria as a result of continued exposure throughout their lifetime. Efforts to implement effective malaria control strategies are increasing, thereby reducing exposure. This project will investigate how such strategies will impact on the development of immunity to malaria and the amount of clinical disease observed in different age groups.
Immunology And Pathogenesis Of Malaria: Basic And Translational Research
Funder
National Health and Medical Research Council
Funding Amount
$727,685.00
Summary
Malaria is one of the most serious infectious diseases of humanity, killing 1-2 million children annually. In order to develop effective vaccines and interventions, it is important to understand both the causes of fatality and how to develop immunity to the disease. This application will continue a very strong international track record in malaria research ranging from basic lab-based molecular studies through to commercial development and population based health studies and policy formulation.
Changing Patterns Of Immunity Following Large Scale Malaria Control Programs In The South West Pacific
Funder
National Health and Medical Research Council
Funding Amount
$299,564.00
Summary
People can develop partial immunity to malaria, which requires ongoing exposure to infection to be maintained. If exposure to infections is completely prevented, people can lose the immunity it has taken them years to develop. In the context of significant ongoing malaria bednet control efforts in the South West Pacific, we will investigate loss or maintenance of the malaria-immune state. This is important for vaccine development and to help us define risk of rebound disease.
Relationship Between Cell-cell Interactions And Disease Severity In Patients With Cerebral Malaria
Funder
National Health and Medical Research Council
Funding Amount
$545,183.00
Summary
Severe malaria is a collection of disease complications that leads to about 2 million deaths each year worldwide. Young children in Africa and young adults in several parts of South-East Asia are particularly affected. Travellers to these regions are also at considerable risk. One of the most dangerous complications of malaria is when the brain becomes affected, which is called cerebral malaria. We still do not understand enough about the changes that link the parasite circulating in the blood w ....Severe malaria is a collection of disease complications that leads to about 2 million deaths each year worldwide. Young children in Africa and young adults in several parts of South-East Asia are particularly affected. Travellers to these regions are also at considerable risk. One of the most dangerous complications of malaria is when the brain becomes affected, which is called cerebral malaria. We still do not understand enough about the changes that link the parasite circulating in the blood with the devastating disturbance of brain function that causes death in some people who develop cerebral malaria. In this project we will investigate some new ideas about how cerebral malaria develops. We will perform a detailed study of brain tissue taken from victims of cerebral malaria and compare the observations with similar ones in children who died of other causes. Then we will work with an experimental model we have developed, in which we put together in culture flasks the various types of cell that are found in the brain lesions in people who die from cerebral malaria. Our aim is to identify some new therapeutic targets for later use in treatment of cerebral malaria patients.Read moreRead less
Assessment Of Transgenic Plants Expressing Malaria Antigens As A Means Of Inducing Protective Immunity
Funder
National Health and Medical Research Council
Funding Amount
$112,000.00
Summary
Malaria infection of humans is one of the most important and deadly infectious diseases in the world, killing more than two million people each year. Traditionally, drugs and insecticides have been used to treat the disease and control its spread. Unfortunately, both of these have become much less effective and there now exist untreatable cases of malaria. Alternative control measures are urgently needed and this project focusses on the development of such an alternative, a vaccine against malar ....Malaria infection of humans is one of the most important and deadly infectious diseases in the world, killing more than two million people each year. Traditionally, drugs and insecticides have been used to treat the disease and control its spread. Unfortunately, both of these have become much less effective and there now exist untreatable cases of malaria. Alternative control measures are urgently needed and this project focusses on the development of such an alternative, a vaccine against malaria using plants transgenic for genes encoding vaccine molecules. Growing these plants not only provides a potentially inexpensive vaccine production system but also offers a potential delivery system such that immunisation may be possible simply through consumption of an edible vaccine. This project intends to investigate the possibility of using transgenic plants expressing malaria antigens to induce protective immunity against malaria infection. The results of this project will provide vitally important information in malaria vaccine production and delivery.Read moreRead less
Using Immunological Principles To Inform Malaria Vaccine Design
Funder
National Health and Medical Research Council
Funding Amount
$577,763.00
Summary
Malaria kills ~420,000 people each year worldwide. While a vaccine does exist, efficacy is poor and protection wanes rapidly. We have made breakthroughs in understanding the immune response to malaria that allow us to design a new generation of malaria vaccines. Based on this we aim to generate a vaccine that induces sustained levels of high-quality antibodies targeting multiple targets on the parasite and so can provide sustained long-term protection.
IL-2-anti-IL-2 Complexes In Immunity To Blood Stage Malaria Infection And Prevention Of Cerebral Immunopathology
Funder
National Health and Medical Research Council
Funding Amount
$586,428.00
Summary
Cerebral malaria is a severe complication of malaria infection, which accounts for a large proportion of malaria-related deaths each year. There is no vaccine against malaria licensed for use in humans. Trial vaccines have been shown to protect poorly against cerebral malaria, and have on occasion, increased the its incidence amongst experimental animals. We aim to develop a safe malaria vaccine that controls malaria parasite numbers in the body, and also prevents cerebral malaria.